As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

Moderna is set to receive $590m in funding from the US Department of Health and Human Services (HHS) to expedite the ...

A Prince George doctor and parent of a prematurely born child is calling for a new life-saving vaccine to be made available ...

Toronto Public Health recorded over 570 cases of influenza and a nearly 11 per cent COVID-19 positivity rate in the second week of January.

Explore the uptake of maternal RSV vaccination and infant protection trends during the 2023-2024 RSV season, focusing on ...

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial ...

Jason McLellan, professor in the Department of Molecular Biosciences and Robert A. Welch Chair in Chemistry at UT, will be ...

Can AI apps like ChatGPT really help investors pick winning FTSE 100 stocks? This Fool's impressed with the results but still ...